An analysis of the utilisation and expenditure of medicines dispensed for the management of severe asthma.

Hdl Handle:
http://hdl.handle.net/10147/302664
Title:
An analysis of the utilisation and expenditure of medicines dispensed for the management of severe asthma.
Authors:
McGowan, B; Bennett, K; Barry, M; Owens, M; O'Connor, M
Affiliation:
Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James's Hospital, James's St, Dublin 8. mcgowab@tcd.ie
Citation:
An analysis of the utilisation and expenditure of medicines dispensed for the management of severe asthma. 2009, 102 (3):73-6 Ir Med J
Journal:
Irish medical journal
Issue Date:
Mar-2009
URI:
http://hdl.handle.net/10147/302664
PubMed ID:
19489193
Abstract:
There are approximately 6,300 people in Ireland with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) and with a fast growing elderly population the incidence of COPD is likely to increase. This study examines the prescribing patterns of medicines dispensed for the management Asthma/COPD in patients over the age of 35 years using the HSE-Primary Care Reimbursement Services (PCRS) prescribing databases. The HSE-PCRS pharmacy claims data, which covers all those over 70 years of age and means tested for those less than 70 years, was analysed for the years 2005/2006. Approximately 26,548 (17.9%) of patients who were prescribed a respiratory drug received inhaled short-acting beta2 agonists in combination with a regular standard-dose inhaled corticosteroid. A further 5,044 (3.4%) were also prescribed a regular inhaled long-acting beta2 agonist (salmeterol or formoterol). A total of 2506 patients (6.2%) on combination therapy were co-prescribed four different anti-asthmatic treatments inclusive of oral prednisolone. A small proportion of the patients prescribed a respiratory drug were co-prescribed nicotine replacement therapy (n = 5177, 3.5%). In total there were 9,728 (6.2%) patients prescribed a mucolytic drug in combination with a respiratory drug and the rate of co-prescribing with antibiotics was 22%. COPD is a debilitating disease that is primarily caused by smoking and is therefore largely preventable. The HSE-PCRS pharmacy claims data is a valuable tool for helping to assess the burden of this disease in the Irish context.
Item Type:
Article
Language:
en
Keywords:
ASTHMA; MEDICATION MANAGEMENT
MeSH:
Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Drug Therapy, Combination; Ethanolamines; Female; Health Expenditures; Health Services; Humans; Incidence; Ireland; Male; Middle Aged; Physician's Practice Patterns; Pulmonary Disease, Chronic Obstructive
ISSN:
0332-3102

Full metadata record

DC FieldValue Language
dc.contributor.authorMcGowan, Ben_GB
dc.contributor.authorBennett, Ken_GB
dc.contributor.authorBarry, Men_GB
dc.contributor.authorOwens, Men_GB
dc.contributor.authorO'Connor, Men_GB
dc.date.accessioned2013-10-03T13:52:31Z-
dc.date.available2013-10-03T13:52:31Z-
dc.date.issued2009-03-
dc.identifier.citationAn analysis of the utilisation and expenditure of medicines dispensed for the management of severe asthma. 2009, 102 (3):73-6 Ir Med Jen_GB
dc.identifier.issn0332-3102-
dc.identifier.pmid19489193-
dc.identifier.urihttp://hdl.handle.net/10147/302664-
dc.description.abstractThere are approximately 6,300 people in Ireland with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) and with a fast growing elderly population the incidence of COPD is likely to increase. This study examines the prescribing patterns of medicines dispensed for the management Asthma/COPD in patients over the age of 35 years using the HSE-Primary Care Reimbursement Services (PCRS) prescribing databases. The HSE-PCRS pharmacy claims data, which covers all those over 70 years of age and means tested for those less than 70 years, was analysed for the years 2005/2006. Approximately 26,548 (17.9%) of patients who were prescribed a respiratory drug received inhaled short-acting beta2 agonists in combination with a regular standard-dose inhaled corticosteroid. A further 5,044 (3.4%) were also prescribed a regular inhaled long-acting beta2 agonist (salmeterol or formoterol). A total of 2506 patients (6.2%) on combination therapy were co-prescribed four different anti-asthmatic treatments inclusive of oral prednisolone. A small proportion of the patients prescribed a respiratory drug were co-prescribed nicotine replacement therapy (n = 5177, 3.5%). In total there were 9,728 (6.2%) patients prescribed a mucolytic drug in combination with a respiratory drug and the rate of co-prescribing with antibiotics was 22%. COPD is a debilitating disease that is primarily caused by smoking and is therefore largely preventable. The HSE-PCRS pharmacy claims data is a valuable tool for helping to assess the burden of this disease in the Irish context.-
dc.language.isoenen
dc.rightsArchived with thanks to Irish medical journalen_GB
dc.subjectASTHMAen_GB
dc.subjectMEDICATION MANAGEMENTen_GB
dc.subject.meshAdrenal Cortex Hormones-
dc.subject.meshAdrenergic beta-Agonists-
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshAlbuterol-
dc.subject.meshAnti-Asthmatic Agents-
dc.subject.meshAsthma-
dc.subject.meshBronchodilator Agents-
dc.subject.meshDrug Therapy, Combination-
dc.subject.meshEthanolamines-
dc.subject.meshFemale-
dc.subject.meshHealth Expenditures-
dc.subject.meshHealth Services-
dc.subject.meshHumans-
dc.subject.meshIncidence-
dc.subject.meshIreland-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.subject.meshPhysician's Practice Patterns-
dc.subject.meshPulmonary Disease, Chronic Obstructive-
dc.titleAn analysis of the utilisation and expenditure of medicines dispensed for the management of severe asthma.en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James's Hospital, James's St, Dublin 8. mcgowab@tcd.ieen_GB
dc.identifier.journalIrish medical journalen_GB
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.